Skip to main content

Avidity Partners Management LP

13F filer · CIK 0001791827
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$624MU.S. long equity reported on 13F
Positions457 new · 14 closed
Net flow last quarter-$449MBuys minus sells
Top 10 positions weight81.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202645 positions
DNTHDianthus Therapeutics, Inc.$205M32.85%3.84%-50.0%Q3 2023
CGONCG Oncology, Inc.$99.4M15.92%1.58%+8.5%Q1 2024
ORKAOruka Therapeutics, Inc.$72.4M11.59%1.25%-50.0%Q3 2024
JBIOJade Biosciences, Inc.$37.8M6.05%2.68%-39.3%Q2 2025
ELVNEnliven Therapeutics, Inc.$27.9M4.47%0.75%-31.3%Q1 2025
CATXPerspective Therapeutics, Inc.$21.5M3.44%5.52%-47.9%Q2 2024
AKTSAktis Oncology, Inc.$15.6M2.50%0.91%-48.3%Q1 2026
PVLAPalvella Therapeutics, Inc.$10.7M1.71%0.49%-50.0%Q4 2025
MOBIMobia Medical, Inc.$10.7M1.71%2.40%NewQ2 2026
RGENRepligen Corp$10.6M1.70%0.14%-50.0%Q2 2025
IMUXImmunic, Inc.$10.3M1.65%4.91%-9.1%Q1 2024
SENSSenseonics Holdings, Inc.$9.09M1.46%3.03%NewQ2 2026
KPTIKaryopharm Therapeutics Inc.$9.03M1.45%4.08%-0.3%Q4 2022
TEVATeva Pharmaceutical Industries Ltd$6.78M1.09%0.02%-69.2%Q1 2025
DXCMDexcom Inc$6.74M1.08%0.03%-47.4%Q3 2022
TEMTempus AI, Inc.$6.08M0.97%Not reported+16.7%Q1 2026
MDTMedtronic plc$5.48M0.88%0.01%-65.0%Q2 2020
VIRVir Biotechnology, Inc.$5.29M0.85%0.31%-66.9%Q2 2020
GPCRStructure Therapeutics Inc.$5.26M0.84%0.05%+25.6%Q2 2023
EHCEncompass Health Corp$4.25M0.68%0.04%-50.0%Q2 2025
TENXTenax Therapeutics, Inc.$3.87M0.62%0.83%-44.8%Q1 2026
NVCTNuvectis Pharma, Inc.$3.68M0.59%0.75%NewQ2 2026
PODDInsulet Corp$3.65M0.59%0.03%+140.0%Q1 2026
BSXBoston Scientific Corp$3.41M0.55%0.01%-33.3%Q3 2020
MSLESatellos Bioscience Inc.$3.01M0.48%30.10%-50.0%Q1 2026
ALMRAlamar Biosciences, Inc.$2.98M0.48%0.16%NewQ2 2026
CNTXContext Therapeutics Inc.$2.77M0.44%5.44%-50.0%Q2 2024
GILDGilead Sciences, Inc.$2.53M0.40%0.00%-50.0%Q2 2024
CRLCharles River Laboratories International, Inc.$2.27M0.36%0.02%Not reportedQ1 2026
PHATPhathom Pharmaceuticals, Inc.$2.17M0.35%0.25%-59.9%Q4 2020
AVLNAvalyn Pharma Inc.$1.98M0.32%0.14%NewQ2 2026
KLRAKailera Therapeutics, Inc.$1.76M0.28%0.06%NewQ2 2026
GMABGenmab A/S$1.37M0.22%Not reported-50.0%Q2 2025
NTLAIntellia Therapeutics, Inc.$1.27M0.20%0.05%-50.0%Q2 2020
CRVSCorvus Pharmaceuticals, Inc.$1.2M0.19%0.10%-65.2%Q1 2026
ODDOddity Tech Ltd$1.06M0.17%Not reported-50.0%Q1 2026
SCYXScynexis Inc$1.06M0.17%2.62%-50.0%Q4 2020
EVMNEvommune, Inc.$997K0.16%0.21%NewQ2 2026
ABTAbbott Laboratories$907K0.15%0.00%Not reportedQ1 2023
BBIOBridgeBio Pharma, Inc.$745K0.12%0.01%Not reportedQ1 2021
PTONPeloton Interactive, Inc.$591K0.09%Not reported-75.0%Q1 2026
LEGNLegend Biotech Corp$433K0.07%0.00%Not reportedQ2 2020
BBOTBridgeBio Oncology Therapeutics, Inc.$334K0.05%0.05%-50.0%Q1 2026
SVRASavara Inc$308K0.05%0.02%Not reportedQ1 2026
TRVITrevi Therapeutics, Inc.$124K0.02%0.00%-50.0%Q1 2026
Q1 2026Reported May 28, 202652 positions
DNTHDianthus Therapeutics, Inc.$361M38.62%7.71%+100.0%Q3 2023
ORKAOruka Therapeutics, Inc.$89.3M9.55%3.03%+130.3%Q3 2024
CGONCG Oncology, Inc.$87.2M9.32%1.46%-12.5%Q1 2024
JBIOJade Biosciences, Inc.$53.9M5.76%5.68%+100.0%Q2 2025
CATXPerspective Therapeutics, Inc.$48.8M5.22%10.61%+276.9%Q2 2024
ELVNEnliven Therapeutics, Inc.$32.2M3.44%1.31%+470.2%Q1 2025
CNTXContext Therapeutics Inc.$24.9M2.66%10.88%+81.6%Q2 2024
TEVATeva Pharmaceutical Industries Ltd$20.6M2.20%0.06%+55.8%Q1 2025
RGENRepligen Corp$18.4M1.96%0.28%+209.3%Q2 2025
PVLAPalvella Therapeutics, Inc.$17.7M1.89%0.98%+625.4%Q4 2025
AKTSAktis Oncology, Inc.$17.2M1.83%1.75%NewQ1 2026
MDTMedtronic plc$16.8M1.79%0.02%+85.9%Q2 2020
VIRVir Biotechnology, Inc.$14.8M1.59%0.97%Not reportedQ2 2020
IMUXImmunic, Inc.$13.9M1.48%54.10%+56.8%Q1 2024
DXCMDexcom Inc$11.6M1.24%0.05%Not reportedQ3 2022
EHCEncompass Health Corp$8.26M0.88%0.08%+165.8%Q2 2025
BSXBoston Scientific Corp$7.22M0.77%0.01%+4.8%Q3 2020
TENXTenax Therapeutics, Inc.$6.94M0.74%1.99%NewQ1 2026
KPTIKaryopharm Therapeutics Inc.$6.44M0.69%4.11%+589.2%Q4 2022
HUMHumana Inc$5.91M0.63%0.02%Not reportedQ3 2020
PHATPhathom Pharmaceuticals, Inc.$5.56M0.59%0.63%+142.0%Q4 2020
GILDGilead Sciences, Inc.$5.4M0.58%0.00%Not reportedQ2 2024
MSLESatellos Bioscience Inc.$5.27M0.56%60.20%NewQ1 2026
TEMTempus AI, Inc.$4.74M0.51%Not reportedNewQ1 2026
SCYXScynexis Inc$3.84M0.41%6.71%+100.0%Q4 2020
ICLRIcon PLC$3.66M0.39%0.04%-3.3%Q4 2022
NTRANatera, Inc.$3.66M0.39%0.01%+52.5%Q3 2020
GPCRStructure Therapeutics Inc.$3.44M0.37%0.04%Not reportedQ2 2023
CRVSCorvus Pharmaceuticals, Inc.$3.43M0.37%0.27%NewQ1 2026
HIMSHims & Hers Health, Inc.$2.92M0.31%Not reportedNewQ1 2026
GMABGenmab A/S$2.67M0.29%Not reported+8.7%Q2 2025
CORTCorcept Therapeutics Inc$2.6M0.28%0.06%+172.7%Q4 2025
CNCCentene Corp$2.29M0.24%0.01%-41.4%Q2 2021
NTLAIntellia Therapeutics, Inc.$1.97M0.21%0.12%Not reportedQ2 2020
PTONPeloton Interactive, Inc.$1.95M0.21%Not reportedNewQ1 2026
ODDOddity Tech Ltd$1.94M0.21%Not reportedNewQ1 2026
AVRAnteris Technologies Global Corp.$1.76M0.19%0.31%NewQ1 2026
MLTXMoonLake Immunotherapeutics$1.75M0.19%0.19%Not reportedQ4 2020
KVUEKenvue Inc.$1.72M0.18%0.01%-57.0%Q3 2025
PODDInsulet Corp$1.72M0.18%0.01%NewQ1 2026
CRLCharles River Laboratories International, Inc.$1.67M0.18%0.02%NewQ1 2026
RVMDRevolution Medicines, Inc.$1.46M0.16%0.01%Not reportedQ2 2022
ABVXAbivax S.A.$1.11M0.12%0.01%NewQ1 2026
ABUSArbutus Biopharma Corp$1.09M0.12%0.13%NewQ1 2026
UNHUnitedhealth Group Inc$1.03M0.11%0.00%Not reportedQ4 2021
ABTAbbott Laboratories$908K0.10%0.00%Not reportedQ1 2023
BBOTBridgeBio Oncology Therapeutics, Inc.$761K0.08%0.11%NewQ1 2026
BBIOBridgeBio Pharma, Inc.$711K0.08%0.01%Not reportedQ1 2021
ACADAcadia Pharmaceuticals Inc$580K0.06%0.02%-75.7%Q4 2020
LEGNLegend Biotech Corp$353K0.04%0.00%Not reportedQ2 2020
Q4 2025Reported Feb 13, 202639 positions
DNTHDianthus Therapeutics, Inc.$86.7M25.01%4.87%-34.3%Q3 2023
CGONCG Oncology, Inc.$61.1M17.64%1.83%-8.0%Q1 2024
JBIOJade Biosciences, Inc.$21.6M6.23%2.84%+24.3%Q2 2025
ORKAOruka Therapeutics, Inc.$20M5.77%1.36%Not reportedQ3 2024
TEVATeva Pharmaceutical Industries Ltd$13M3.76%0.04%-18.2%Q1 2025
BSXBoston Scientific Corp$10.9M3.15%0.01%-30.3%Q3 2020
MDTMedtronic plc$10.3M2.98%0.01%-43.6%Q2 2020
CATXPerspective Therapeutics, Inc.$8.83M2.55%4.32%+7.2%Q2 2024
ALNYAlnylam Pharmaceuticals, Inc.$8.35M2.41%0.02%Not reportedQ1 2021
RGENRepligen Corp$8.24M2.38%0.09%+115.9%Q2 2025
CNTXContext Therapeutics Inc.$8.09M2.33%5.99%-38.7%Q2 2024
MCKMckesson Corp$7.81M2.25%0.01%+64.1%Q2 2020
ICLRIcon PLC$6.03M1.74%0.04%Not reportedQ4 2022
AAgilent Technologies, Inc.$5.65M1.63%0.01%Not reportedQ4 2023
PFEPfizer Inc$5.07M1.46%0.00%-44.4%Q3 2021
CNCCentene Corp$4.91M1.42%0.02%Not reportedQ2 2021
KVUEKenvue Inc.$4.02M1.16%0.01%-12.2%Q3 2025
DHRDanaher Corp$3.89M1.12%0.00%-68.9%Q3 2023
TMOThermo Fisher Scientific Inc.$3.88M1.12%0.00%-64.6%Q3 2020
NVONovo Nordisk A S$3.42M0.99%Not reportedNewQ4 2025
PHATPhathom Pharmaceuticals, Inc.$3.42M0.99%0.29%-32.7%Q4 2020
EHCEncompass Health Corp$3.35M0.97%0.03%-24.6%Q2 2025
CICigna Group$3.19M0.92%0.00%-30.1%Q1 2021
CORCencora, Inc.$3.17M0.92%0.00%-50.5%Q1 2023
INSMINSMED Inc$3.08M0.89%0.01%+52.6%Q2 2021
WATWaters Corp$3.08M0.89%0.01%NewQ4 2025
ACADAcadia Pharmaceuticals Inc$2.86M0.82%0.06%-25.8%Q4 2020
GMABGenmab A/S$2.83M0.82%Not reported-62.9%Q2 2025
NTRANatera, Inc.$2.7M0.78%0.01%-83.2%Q3 2020
IMUXImmunic, Inc.$2.51M0.72%39.04%Not reportedQ1 2024
ACHCAcadia Healthcare Company, Inc.$2.4M0.69%0.19%Not reportedQ2 2022
ITGRInteger Holdings Corp$2.34M0.67%0.09%NewQ4 2025
ELVNEnliven Therapeutics, Inc.$2.16M0.62%0.24%Not reportedQ1 2025
PVLAPalvella Therapeutics, Inc.$2.02M0.58%0.16%NewQ4 2025
HQYHealthequity, Inc.$1.55M0.45%0.02%-33.2%Q1 2025
SCYXScynexis Inc$1.32M0.38%38.25%-37.9%Q4 2020
IQVIqvia Holdings Inc.$992K0.29%0.00%NewQ4 2025
KPTIKaryopharm Therapeutics Inc.$990K0.29%0.73%Not reportedQ4 2022
CORTCorcept Therapeutics Inc$766K0.22%0.02%NewQ4 2025
Q3 2025Reported Nov 14, 202543 positions
DNTHDianthus Therapeutics, Inc.$126M28.70%7.48%+83.8%Q3 2023
CGONCG Oncology, Inc.$64.5M14.68%2.05%+6.7%Q1 2024
MDTMedtronic plc$18.2M4.13%0.01%Not reportedQ2 2020
BSXBoston Scientific Corp$16M3.65%0.01%-48.9%Q3 2020
ORKAOruka Therapeutics, Inc.$12.7M2.89%1.37%+87.6%Q3 2024
BMYBristol Myers Squibb Co$11.6M2.64%0.01%Not reportedQ3 2024
NTRANatera, Inc.$11.3M2.58%0.05%-64.7%Q3 2020
DHRDanaher Corp$10.8M2.47%0.01%-39.0%Q3 2023
TEVATeva Pharmaceutical Industries Ltd$10.3M2.34%0.04%-26.0%Q1 2025
CATXPerspective Therapeutics, Inc.$10.3M2.34%4.03%+61.1%Q2 2024
JBIOJade Biosciences, Inc.$9.73M2.21%3.45%Not reportedQ2 2025
PFEPfizer Inc$9.34M2.12%0.01%Not reportedQ3 2021
TMOThermo Fisher Scientific Inc.$9.17M2.09%0.01%-36.2%Q3 2020
CNTXContext Therapeutics Inc.$8.7M1.98%9.78%+20.1%Q2 2024
GMABGenmab A/S$7.61M1.73%Not reported-61.8%Q2 2025
MTSRMetsera, Inc.$7.35M1.67%0.13%NewQ3 2025
UNHUnitedhealth Group Inc$6.15M1.40%0.00%-44.4%Q4 2021
ARVNArvinas, Inc.$5.95M1.35%0.99%+187.2%Q2 2020
CORCencora, Inc.$5.94M1.35%0.01%-42.1%Q1 2023
EHCEncompass Health Corp$5.32M1.21%0.04%-43.4%Q2 2025
JNJJohnson & Johnson$4.97M1.13%0.00%Not reportedQ1 2022
CICigna Group$4.78M1.09%0.01%Not reportedQ1 2021
ABBVAbbVie Inc.$4.58M1.04%0.00%Not reportedQ2 2020
MCKMckesson Corp$4.48M1.02%0.00%-57.0%Q2 2020
CARLCarlsmed, Inc.$4.31M0.98%1.21%NewQ3 2025
KVUEKenvue Inc.$4.3M0.98%0.01%NewQ3 2025
IMUXImmunic, Inc.$4.14M0.94%4.76%-16.3%Q1 2024
ARQTArcutis Biotherapeutics, Inc.$4.04M0.92%0.18%-20.0%Q3 2022
EXKEndeavour Silver Corp$4.03M0.92%0.03%-79.3%Q4 2020
PHATPhathom Pharmaceuticals, Inc.$3.6M0.82%0.43%-71.3%Q4 2020
RGENRepligen Corp$3.11M0.71%0.04%-78.1%Q2 2025
ACADAcadia Pharmaceuticals Inc$3.07M0.70%0.09%Not reportedQ4 2020
ASNDAscendis Pharma A/S$2.88M0.66%0.02%Not reportedQ2 2020
ELVNEnliven Therapeutics, Inc.$2.87M0.65%0.24%+1141.6%Q1 2025
BEAMBeam Therapeutics Inc.$2.72M0.62%0.11%-72.6%Q1 2025
SCYXScynexis Inc$2.58M0.59%7.99%+172.6%Q4 2020
HQYHealthequity, Inc.$2.4M0.55%0.03%-72.5%Q1 2025
WVEWave Life Sciences, Inc.$2.18M0.50%0.19%Not reportedQ2 2024
XENEXenon Pharmaceuticals Inc.$2.14M0.49%0.07%-50.5%Q2 2022
AKROAkero Therapeutics, Inc.$1.92M0.44%0.05%-69.8%Q3 2022
INSMINSMED Inc$1.67M0.38%0.01%-80.3%Q2 2021
KPTIKaryopharm Therapeutics Inc.$880K0.20%1.55%Not reportedQ4 2022
IMRXImmuneering Corp$636K0.14%0.35%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.